BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18369098)

  • 1. Sustained long-term engraftment and transgene expression of peripheral blood CD34+ cells transduced with third-generation lentiviral vectors.
    Tesio M; Gammaitoni L; Gunetti M; Leuci V; Pignochino Y; Jordaney N; Capellero S; Cammarata C; Caione L; Migliaretti G; Fagioli F; Tabilio A; Aglietta M; Piacibello W
    Stem Cells; 2008 Jun; 26(6):1620-7. PubMed ID: 18369098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient lentiviral gene transfer in CD34+ and CD34+/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation.
    GĂ©ronimi F; Richard E; Redonnet-Vernhet I; Lamrissi-Garcia I; Lalanne M; Ged C; Moreau-Gaudry F; De Verneuil H
    Stem Cells; 2003; 21(4):472-80. PubMed ID: 12832700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.
    Guenechea G; Gan OI; Inamitsu T; Dorrell C; Pereira DS; Kelly M; Naldini L; Dick JE
    Mol Ther; 2000 Jun; 1(6):566-73. PubMed ID: 10933981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells.
    Salmon P; Arrighi JF; Piguet V; Chapuis B; Zubler RH; Trono D; Kindler V
    J Gene Med; 2001; 3(4):311-20. PubMed ID: 11529660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer into baboon repopulating cells: A comparison of Flt-3 Ligand and megakaryocyte growth and development factor versus IL-3 during ex vivo transduction.
    Kurre P; Morris J; Horn PA; Harkey MA; Andrews RG; Kiem HP
    Mol Ther; 2001 Jun; 3(6):920-7. PubMed ID: 11407906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.
    Ailles L; Schmidt M; Santoni de Sio FR; Glimm H; Cavalieri S; Bruno S; Piacibello W; Von Kalle C; Naldini L
    Mol Ther; 2002 Nov; 6(5):615-26. PubMed ID: 12409260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
    Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
    Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient transduction and engraftment of G-CSF-mobilized peripheral blood CD34+ cells in nonhuman primates using GALV-pseudotyped gammaretroviral vectors.
    Beard BC; Mezquita P; Morris JC; Kiem HP
    Mol Ther; 2006 Aug; 14(2):212-7. PubMed ID: 16631413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.
    Piacibello W; Bruno S; Sanavio F; Droetto S; Gunetti M; Ailles L; Santoni de Sio F; Viale A; Gammaitoni L; Lombardo A; Naldini L; Aglietta M
    Blood; 2002 Dec; 100(13):4391-400. PubMed ID: 12453876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells.
    Cai S; Hartwell JR; Cooper RJ; Juliar BE; Kreklau E; Abonour R; Goebel WS; Pollok KE
    Mol Ther; 2006 May; 13(5):1016-26. PubMed ID: 16426896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34+ cells in indirect co-culture.
    Xie C; Jia B; Xiang Y; Wang L; Wang G; Huang G; McNiece IK; Wang J
    Cell Tissue Res; 2006 Oct; 326(1):101-10. PubMed ID: 16685532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
    Hirai M; LaFace D; Robinson S; Kelsey L; Johnson R; Wen SF; Warkentin P; Mills K; Vaillancourt M; Chavez J; Leutzinger C; Sumegi J; Neugebauer S; Lehman J; Talmadge C; Maneval D; Talmadge J
    Cancer Gene Ther; 2001 Dec; 8(12):936-47. PubMed ID: 11781656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector.
    van der Loo JC; Liu BL; Goldman AI; Buckley SM; Chrudimsky KS
    Hum Gene Ther; 2002 Jul; 13(11):1317-30. PubMed ID: 12162814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.